1,519
Views
49
CrossRef citations to date
0
Altmetric
Author's View

Trial watch

Immunostimulatory cytokines in cancer therapy

, , , , , , , & show all
Article: e29030 | Received 25 Apr 2014, Accepted 26 Apr 2014, Published online: 03 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (23)

Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini & Jérôme Galon. (2023) Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response. OncoImmunology 12:1.
Read now
Gabriela Bindea, Bernhard Mlecnik & Jérôme Galon. (2021) Expand to shield: IL-15 and in situ lymphocytic proliferation. OncoImmunology 10:1.
Read now
V. Cervera-Carrascon, M. Siurala, J. M. Santos, R. Havunen, S. Tähtinen, P. Karell, S. Sorsa, A. Kanerva & A. Hemminki. (2018) TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade. OncoImmunology 7:5.
Read now
KJ Allan, David F Stojdl & SL Swift. (2016) High-throughput screening to enhance oncolytic virus immunotherapy. Oncolytic Virotherapy 5, pages 15-25.
Read now
Erika Vacchelli, Norma Bloy, Fernando Aranda, Aitziber Buqué, Isabelle Cremer, Sandra Demaria, Alexander Eggermont, Silvia Chiara Formenti, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunotherapy plus radiation therapy for oncological indications. OncoImmunology 5:9.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy. OncoImmunology 5:6.
Read now
Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fucikova, Jérôme Galon, Jean-Marc Limacher, Xavier Preville, Catherine Sautès-Fridman, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Oncolytic viruses and cancer therapy. OncoImmunology 5:2.
Read now
Erika Vacchelli, Fernando Aranda, Norma Bloy, Aitziber Buqué, Isabelle Cremer, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch—Immunostimulation with cytokines in cancer therapy. OncoImmunology 5:2.
Read now
Jonathan Pol, Guido Kroemer & Lorenzo Galluzzi. (2016) First oncolytic virus approved for melanoma immunotherapy. OncoImmunology 5:1.
Read now
Lorenzo Galluzzi, Alexander Eggermont & Guido Kroemer. (2016) Doubling the blockade for melanoma immunotherapy. OncoImmunology 5:1.
Read now
Amy L MacNeill. (2015) On the potential of oncolytic virotherapy for the treatment of canine cancers. Oncolytic Virotherapy 4, pages 95-107.
Read now
Eike Binz & Ulrich M Lauer. (2015) Chemovirotherapy: combining chemotherapeutic treatment with oncolytic virotherapy. Oncolytic Virotherapy 4, pages 39-48.
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Pierre Combe, Eleonore de Guillebon, Constance Thibault, Clémence Granier, Eric Tartour & Stéphane Oudard. (2015) Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma. OncoImmunology 4:5.
Read now
Daniel O Villarreal & David B Weiner. (2015) IL-33 isoforms: their future as vaccine adjuvants?. Expert Review of Vaccines 14:4, pages 489-492.
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Erika Vacchelli, Jonathan Pol, Norma Bloy, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jérôme Galon, Aurélien Marabelle, Holbrook Kohrt, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. OncoImmunology 4:1.
Read now
Lorenzo Galluzzi, Guido Kroemer & Alexander Eggermont. (2014) Novel immune checkpoint blocker approved for the treatment of advanced melanoma. OncoImmunology 3:11.
Read now
Norma Bloy, Jonathan Pol, Fernando Aranda, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fučíková, Jérôme Galon, Eric Tartour, Radek Spisek, Madhav V. Dhodapkar, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: Dendritic cell-based anticancer therapy. OncoImmunology 3:11.
Read now
Norma Bloy, Jonathan Pol, Gwenola Manic, Ilio Vitale, Alexander Eggermont, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch: Radioimmunotherapy for oncological indications. OncoImmunology 3:9.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 3:10.
Read now
Gwenola Manic, Florine Obrist, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2014) Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology 1:1.
Read now

Articles from other publishers (26)

Christoph Jindra, Edmund K. Hainisch & Sabine Brandt. (2023) Immunotherapy of Equine Sarcoids—From Early Approaches to Innovative Vaccines. Vaccines 11:4, pages 769.
Crossref
Nader Salari, Mohsen Kazeminia, Amin Hosseinian-Far, Kamran Mansouri, Masoud Mohammadi & Farshid Alazmani Noodeh. (2021) The Effect of Polymorphism A/T 251 of the IL-8 Gene on Breast Cancer: A Systematic Review and Meta-Analysis. Indian Journal of Gynecologic Oncology 19:4.
Crossref
Rossella Capochiani de Iudicibus, Petr Tomek, Brian D. Palmer, Sofian M. Tijono, Jack U. Flanagan & Lai-Ming Ching. (2021) Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay. Bioorganic & Medicinal Chemistry 39, pages 116160.
Crossref
Shujing Liang, Menglin Sun, Yonglin Lu, Shuo Shi, Yiting Yang, Yun Lin, Chan Feng, Jie Liu & Chunyan Dong. (2020) Cytokine-induced killer cells-assisted tumor-targeting delivery of Her-2 monoclonal antibody-conjugated gold nanostars with NIR photosensitizer for enhanced therapy of cancer. Journal of Materials Chemistry B 8:36, pages 8368-8382.
Crossref
Laura Martin-Hijano & Bruno SainzJr.Jr.. (2020) The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway. Frontiers in Immunology 11.
Crossref
Julia Dickow, Sandra Francois, Rouven-Luca Kaiserling, Anna Malyshkina, Ingo Drexler, Astrid Maria Westendorf, Karl Sebastian Lang, Mario L. Santiago, Ulf Dittmer & Kathrin Sutter. (2019) Diverse Immunomodulatory Effects of Individual IFNα Subtypes on Virus-Specific CD8+ T Cell Responses. Frontiers in Immunology 10.
Crossref
Brian Salmons & Walter H. Gunzburg. (2018) Release characteristics of cellulose sulphate capsules and production of cytokines from encapsulated cells. International Journal of Pharmaceutics 548:1, pages 15-22.
Crossref
David T. Riglar & Pamela A. Silver. (2018) Engineering bacteria for diagnostic and therapeutic applications. Nature Reviews Microbiology 16:4, pages 214-225.
Crossref
Alexander M. M. Eggermont & Caroline Robert. 2018. Oncoimmunology. Oncoimmunology 579 591 .
Zahra Valedkarimi, Hadi Nasiri, Leili Aghebati-Maleki & Jafar Majidi. (2017) Antibody-cytokine fusion proteins for improving efficacy and safety of cancer therapy. Biomedicine & Pharmacotherapy 95, pages 731-742.
Crossref
Yogesh R. Suryawanashi, Tiantian Zhang, Helene M. Woyczesczyk, John Christie, Emily Byers, Steven Kohler, Robert Eversole, Charles Mackenzie & Karim Essani. (2017) T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors. Medical Oncology 34:6.
Crossref
Erika Elgström, Tomas G Ohlsson & Sophie E Eriksson. (2017) Cytokine evaluation in untreated and radioimmunotherapy-treated tumors in an immunocompetent rat model. Tumor Biology 39:4, pages 101042831769755.
Crossref
Virginie Verkarre, H?l?ne Roussel, Cl?mence Granier, Eric Tartour & Yves Allory. (2017) Immunoth?rapie en uropathologie. Annales de Pathologie 37:1, pages 90-100.
Crossref
Zehai Song, Hang Chang, Na Han, Zhihui Liu, Ye Liu, Hui Wang, Jingxuan Shao, Zhonglin Wang, Hao Gao & Jun Yin. (2017) He-Wei granules (HWKL) combat cisplatin-induced nephrotoxicity and myelosuppression in rats by inhibiting oxidative stress, inflammatory cytokines and apoptosis. RSC Advances 7:32, pages 19794-19807.
Crossref
Ruth Ganss. 2017. Cytokine Effector Functions in Tissues. Cytokine Effector Functions in Tissues 239 256 .
Alexander M. M. Eggermont, Dirk Schadendorf & Caroline Robert. 2017. Melanoma Development. Melanoma Development 427 436 .
T. Carter, H. Shaw, D. Cohn-Brown, K. Chester & P. Mulholland. (2016) Ipilimumab and Bevacizumab in Glioblastoma. Clinical Oncology 28:10, pages 622-626.
Crossref
Lorenzo Galluzzi, José Manuel Bravo-San Pedro, Oliver Kepp & Guido Kroemer. (2016) Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences 73:11-12, pages 2405-2410.
Crossref
Anna Johansson, Juliana Hamzah & Ruth Ganss. (2016) More than a scaffold: Stromal modulation of tumor immunity. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1865:1, pages 3-13.
Crossref
Paola Perego & Jacques Robert. (2015) Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy. Cancer Chemotherapy and Pharmacology 77:1, pages 5-18.
Crossref
Dafne Müller. (2015) Antibody fusions with immunomodulatory proteins for cancer therapy. Pharmacology & Therapeutics 154, pages 57-66.
Crossref
L. Apetoh, S. Ladoire, G. Coukos & F. Ghiringhelli. (2015) Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?. Annals of Oncology 26:9, pages 1813-1823.
Crossref
Jitka Fucikova, Irena Moserova, Linda Urbanova, Lucillia Bezu, Oliver Kepp, Isabelle Cremer, Cyril Salek, Pavel Strnad, Guido Kroemer, Lorenzo Galluzzi & Radek Spisek. (2015) Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology 6.
Crossref
Laurence Zitvogel, Lorenzo Galluzzi, Oliver Kepp, Mark J. Smyth & Guido Kroemer. (2015) Type I interferons in anticancer immunity. Nature Reviews Immunology 15:7, pages 405-414.
Crossref
Alexander M.M. Eggermont, Michele Maio & Caroline Robert. (2015) Immune Checkpoint Inhibitors in Melanoma Provide the Cornerstones for Curative Therapies. Seminars in Oncology 42:3, pages 429-435.
Crossref
Benjamin Ruf & Ulrich M Lauer. (2015) Assessment of current virotherapeutic application schemes: ?hit hard and early? versus ?killing softly??. Molecular Therapy - Oncolytics 2, pages 15018.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.